Frankis Almaguel
Nuclear Medicine · San Bernardino, CANPI 1427433762
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,250 of the $13,255 with a category attached, or 62.2%. Lantheus Medical Imaging, Inc. accounts for 75.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $11,168 and has fallen 84.7% since, to $1,708 in 2025. Among nuclear medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $358.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$10K
- Telix Pharmaceuticals$2K
- Novartis$302
- Siemens Medical Solutions USA, Inc.$199
- Novocure Inc.$175
- Progenics Pharmaceuticals, Inc.$152
- plus $313 from 3 others
Across 28 payments — averaging $32,518 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$529K
- E.r. Squibb & Sons, L.L.C.$182K
- Genentech, Inc.$136K
- Lantheus Medical Imaging, Inc.$58K
- Telix Pharmaceuticals$7K
What the payments were for
- Speaking & faculty fees$8,25062%
- Travel & lodging$2,50519%
- Food & beverage$2,50119%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 7 | $9,976 |
| Telix Pharmaceuticals | 15 | $2,139 |
| Novartis | 4 | $302 |
| Siemens Medical Solutions USA, Inc. | 4 | $199 |
| Novocure Inc. | 1 | $175 |
| Progenics Pharmaceuticals, Inc. | 3 | $152 |
| GE HealthCare | 1 | $143 |
| Curium US LLC | 1 | $125 |
| Eli Lilly | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,255 in reported general payments places this provider in the 95th percentile of 110 nuclear medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in San Bernardino
- Hossein JadvarLos Angeles$294K
- Michael DaeSan Francisco$45K
- Ernest BelezzuoliSan Diego$39K
- Johannes CzerninLos Angeles$24K
- Gholam BerenjiLos Angeles$15K
- Shahram BonyadlouLos Angeles$12K
- Leonard ValentinoRedwood City$8K
- Randy YehSylmar$8K
- Daniel SilvermanLos Angeles$8K
- Ernie MethMurrieta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.